A detailed history of Inspirion Wealth Advisors, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Inspirion Wealth Advisors, LLC holds 354,977 shares of PDSB stock, worth $1.04 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
354,977
Previous 336,594 5.46%
Holding current value
$1.04 Million
Previous $1.67 Million 15.97%
% of portfolio
0.23%
Previous 0.3%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$3.85 - $6.59 $70,774 - $121,143
18,383 Added 5.46%
354,977 $1.41 Million
Q4 2023

Jan 10, 2024

BUY
$3.95 - $6.58 $22,594 - $37,637
5,720 Added 1.73%
336,594 $1.67 Million
Q3 2023

Oct 13, 2023

BUY
$4.8 - $6.4 $1,344 - $1,792
280 Added 0.08%
330,874 $1.67 Million
Q2 2023

Jul 20, 2023

BUY
$5.03 - $9.9 $80,027 - $157,509
15,910 Added 5.06%
330,594 $1.66 Million
Q1 2023

Apr 07, 2023

BUY
$5.68 - $11.99 $3,209 - $6,774
565 Added 0.18%
314,684 $1.94 Million
Q3 2022

Oct 18, 2022

BUY
$3.04 - $5.79 $1,368 - $2,605
450 Added 0.14%
314,119 $933,000
Q2 2022

Jul 27, 2022

BUY
$3.05 - $6.68 $112,999 - $247,487
37,049 Added 13.39%
313,669 $1.15 Million
Q1 2022

Apr 14, 2022

BUY
$4.78 - $8.43 $144,260 - $254,417
30,180 Added 12.25%
276,620 $1.71 Million
Q4 2021

Jan 21, 2022

SELL
$7.76 - $14.35 $57,711 - $106,720
-7,437 Reduced 2.93%
246,440 $2 Million
Q3 2021

Oct 08, 2021

BUY
$9.33 - $17.08 $5,737 - $10,504
615 Added 0.24%
253,877 $3.78 Million
Q2 2021

Jul 16, 2021

BUY
$4.35 - $12.86 $18,922 - $55,941
4,350 Added 1.75%
253,262 $3.18 Million
Q1 2021

Apr 15, 2021

BUY
$2.28 - $6.81 $22,537 - $67,316
9,885 Added 4.14%
248,912 $1.13 Million
Q4 2020

Jan 22, 2021

BUY
$1.91 - $2.67 $477 - $667
250 Added 0.1%
239,027 $512,000
Q3 2020

Oct 14, 2020

BUY
$1.67 - $4.67 $344,415 - $963,126
206,237 Added 633.8%
238,777 $556,000
Q2 2020

Jul 09, 2020

BUY
$0.65 - $2.6 $5,957 - $23,829
9,165 Added 39.21%
32,540 $65,000
Q1 2020

Apr 23, 2020

BUY
$0.67 - $3.04 $335 - $1,520
500 Added 2.19%
23,375 $17,000
Q4 2019

Jan 14, 2020

BUY
$2.08 - $4.07 $1,664 - $3,256
800 Added 3.62%
22,875 $61,000
Q3 2019

Oct 22, 2019

BUY
$3.38 - $6.71 $2,450 - $4,864
725 Added 3.4%
22,075 $75,000
Q2 2019

Jul 15, 2019

BUY
$5.44 - $8.68 $116,144 - $185,318
21,350 New
21,350 $128,000

Others Institutions Holding PDSB

About PDS Biotechnology Corp


  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $83.4M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Inspirion Wealth Advisors, LLC Portfolio

Follow Inspirion Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspirion Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspirion Wealth Advisors, LLC with notifications on news.